Considerations of antibiotic therapy duration in community- and hospital-acquired bacterial infections

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 11, 2012, Pages 2570-2575

  Esposito, Silvano ^a   Esposito, Isabella ^a   Leone, Sebastiano ^b  

^a UNIVERSITY HOSPITAL SAN GIOVANNI DI DIO E RUGGI D ARAGONA   (Italy)

^b Hospital of Legnago   (Italy)

Author keywords

Antibiotic resistance; Appropriate therapy; Duration of antibiotic therapy

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CEPHALOSPORIN; COTRIMOXAZOLE; ERTAPENEM; FOSFOMYCIN; GENTAMICIN; LEVOFLOXACIN; NETILMICIN; PENICILLIN G; QUINOLONE; RIFAMPICIN; VANCOMYCIN;

ABDOMINAL ABSCESS; ACUTE PYELONEPHRITIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; APPENDICITIS; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; BACTERIAL SINUSITIS; BLOODSTREAM INFECTION; CATHETER INFECTION; CHRONIC OSTEOMYELITIS; COMMUNITY ACQUIRED BACTERIAL INFECTION; COMMUNITY ACQUIRED PNEUMONIA; CYSTITIS; DEBRIDEMENT; DRUG EFFICACY; DRUG EXPOSURE; HIP PROSTHESIS; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL INFECTION; HUMAN; KNEE PROSTHESIS; LOW DRUG DOSE; NONHUMAN; PERIPROSTHETIC JOINT INFECTION; PERITONITIS; PHARYNGITIS; PROSTHETIC VALVE ENDOCARDITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE DRUG DOSE; STREPTOCOCCUS GROUP A; TONSILLO PHARYNGITIS; TREATMENT DURATION; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; TIME FACTORS;

EID: 84866952997     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks277     Document Type: Review

References (59)

1. Fauci AS, Morens DM. The perpetual challenge of infectious diseases. N Engl J Med 2012; 366: 454-61.
2. Wilcox MH. The tide of antimicrobial resistance and selection. Int J Antimicrob Agents 2009; 34 Suppl 3: 6-10.
3. Leone S, Stefani S, Venditti M et al. Intra-abdominal infections: model of antibiotic stewardship in an era with limited antimicrobial options. Int J Antimicrob Agents 2011; 38: 271-2.
4. Rice LB. The Maxwell Finland Lecture: For the duration-rational antibiotic administration in an era of antimicrobial resistance and Clostridium difficile. Clin Infect Dis 2008; 46: 491-6.
5. Hayashi Y, Paterson DL. Strategies for reduction in duration of antibiotic use in hospitalized patients. Clin Infect Dis 2011; 52: 1232-40.
6. Agarwal R, Schwartz DN. Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review. Clin Infect Dis 2011; 53: 379-87.
7. Bisno AL, Gerber MA, Gwaltney JM Jr et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002; 35: 113-25.
8. Esposito S, Noviello S, Ianniello F. Treatment of streptococcal tonsillo-pharyngitis in paediatric patients: short-course therapy with cefaclor. Infez Med 2000; 4: 227-33.
9. Altamimi S, Khalil A, Khalaiwi KA et al. Short versus standard duration antibiotic therapy for acute streptococcal pharyngitis in children. Cochrane Database Syst Rev 2009; issue 1: CD004872.
10. Chow AW, Benninger MS, Brook I et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 2012; 54: 72-112.
11. Falagas ME, Karageorgopoulos DE, Grammatikos AP et al. Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials. Br J Clin Pharmacol 2008; 67: 161-71.
12. Dunbar LM, Wunderink RG, Habib MP et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 2003; 37: 752-60.
13. Dimopoulos G, Matthaiou DK, Karageorgopoulos DE et al. Shortversus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis. Drugs 2008; 68: 1841-54.
14. Schuetz P, Christ-Crain M, Thomann R et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections. The ProHOSP randomized controlled trial. JAMA 2009; 302: 1059-66.
15. Dennesen PJ, van der Ven AJ, Kessels AG et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilatorassociated pneumonia. Am J Respir Crit Care Med 2001; 163: 1371-5.
16. Micek ST, Ward S, Fraser VJ et al. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilatorassociated pneumonia. Chest 2004; 125: 1791-9.
17. Ibrahim EH, Ward S, Sherman G et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29: 1109-15.
18. Pugh R, Grant C, Cooke RP et al. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst Rev 2011; issue 10: CD007577.
19. Gupta K, Hooton TM, Naber KG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52: 103-20.
20. Lutters M, Vogt-Ferrier NB. Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database Syst Rev 2008; issue 3: CD001535.
21. Milo G, Katchman EA, Paul M et al. Duration of antibacterial treatment for uncomplicated urinary tract infection in women. Cochrane Database Syst Rev 2005; issue 2: CD004682.
22. Kyriakidou KG, Rafailidis P, Matthaiou DK et al. Short- versus long-course antibiotic therapy for acute pyelonephritis in adolescents and adults: a meta-analysis of randomized controlled trials. Clin Ther 2008; 30: 1859-68.
23. Hooton TM, Bradley SF, Cardenas DD et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 625-63.
24. Nicolle LE, Bradley S, Colgan R et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643-54.
25. Widmer M, Gülmezoglu AM, Mignini L et al. Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst Rev 2011; issue 12: CD000491.
26. Esposito S, Carosi G, Leone S. Current guidelines for the treatment of intra-abdominal infections. Infez Med 2008; 16 Suppl 1: 46-52.
27. Esposito S, Leone S, Carosi G. Analysis of current guidelines for intra-abdominal infections. J Chemother 2009; 21 Suppl 1: 30-5.
28. Solomkin JS, Mazuski JE, Bradley JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 133-64.
29. Snelling CM, Poenaru D, Drover JW. Minimum postoperative antibiotic duration in advanced appendicitis in children: a review. Pediatr Surg Int 2004; 20: 838-45.
30. Basoli A, Chirletti P, Cirino E et al. A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs ≥5 days in community-acquired intraabdominal infection. J Gastrointest Surg 2008; 12: 592-600.
31. Esposito S, Leone S, Bassetti M et al. Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults. Infection 2009; 37: 478-96.
32. Esposito S, Leone S, Noviello S et al. Outpatient parenteral antibiotic therapy for bone and joint infections: an Italian multicenter study. J Chemother 2007; 19: 417-22.
33. Esposito S, Leone S. Prosthetic joint infections: microbiology, diagnosis, management and prevention. Int J Antimicrob Agents 2008; 32: 287-93.
34. Puhto AP, Puhto T, Syrjala H. Short-course antibiotics for prosthetic joint infections treated with prosthesis retention. Clin Microbiol Infect 2011; doi:10.1111/j.1469-0691.2011.03693.x
35. Bernard L, Legout L, Zürcher-Pfund L et al. Six weeks of antibiotic treatment is sufficient following surgery for septic arthroplasty. J Infect 2010; 61: 125-32.
36. Leone S, Borré S, Monforte A et al. Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections. Int J Infect Dis 2010; 14 Suppl 4: 67-77.
37. Dellinger RP, Levy MM, Carlet JM et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
38. Havey TC, Fowler RA, Daneman N. Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis. Crit Care 2011; 15: R267.
39. Daneman N, Shore K, Pinto R et al. Antibiotic treatment duration for bloodstream infections in critically ill patients: a national survey of Canadian infectious diseases and critical care specialists. Int J Antimicrob Agents 2011; 38: 480-5.
40. Corey GR, Stryjewski ME, Everts RJ. Short-course therapy for bloodstream infections in immunocompetent adults. Int J Antimicrob Agents 2009; 34 Suppl 4: 47-51.
41. Falcone M, Russo A, Pompeo ME et al. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy. Int J Antimicrob Agents 2012; 39: 64-8.
42. Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011; 66 Suppl 2: 33-40.
43. Habib G, Hoen B, Tornos P et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30: 2369-413.
44. Baddour LM, Wilson WR, Bayer AS et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111: e394-434.
45. Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for days: a prospective multicenter study. Clin Infect Dis 1995; 21: 1406-10.
46. Sexton DJ, Tenenbaum MJ, WilsonWR et al. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. Clin Infect Dis 1998; 27: 1470-74.
47. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med 1988; 109: 619-24.
48. Torres-Tortosa M, de Cueto M, Vergara A et al. Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cá diz. Eur J Clin Microbiol 1994; 13: 559-64.
49. DiNubile MJ. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users. Ann Intern Med 1994; 121: 873-76.
50. Ribera E, Gomez-Jimenez J, Cortes E et al. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis: a randomized, controlled trial. Ann Intern Med 1996; 125: 969-74.
51. Fortun J, Navas E, Martinez-Beltran J et al. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. Clin Infect Dis 2001; 33: 120-25.
52. Morris AJ, Drinkovic D, Pottumarthy S et al. Bacteriological outcome after valve surgery for active infective endocarditis: implications for duration of treatment after surgery. Clin Infect Dis 2005; 2: 187-94.
53. Muñoz P, Giannella M, Scoti F et al. Two weeks of postsurgical therapy may be enough for high-risk cases of endocarditis caused by Streptococcus viridans or Streptococcus bovis. Clin Microbiol Infect 2012; 18: 293-9.
54. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; Suppl 4: 131-8.
55. Leone S, Fiore M, Felaco FM et al. Early and timely therapy: when to interrupt antibiotic therapy in nosocomial acquired pneumonia? Infez Med 2007; 15: 16-23.
56. Esposito S, Leone S, Noviello S et al. Management of severe bacterial infections and role of the infectious disease specialist: results of an interview-based survey. Infez Med 2004; 12: 90-100.
57. Tam VH, Louie A, Fritsche TR et al. Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobial. J Infect Dis 2007; 195: 1818-27.
58. Costelloe C, Metcalfe C, Lovering A et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010; 340: c2096.
59. Smirnova MV, Vostrov SN, Strukova EV et al. The impact of duration of antibiotic exposure on bacterial resistance predictions using in vitro dynamic models. J Antimicrob Chemother 2009; 64: 815-20.